[ad_1] Neurolixis to present NLX-112 results at Barcelona WPC meeting A First-in-Class Highly Selective and Efficacious Serotonin 5-HT1A Receptor Agonist for treatment of Parkinson’s Disease The...
[ad_1] Pamela Quinn choreographed an emotional performance of 50 people with Parkinson’s from all over the world at the World Parkinson’s Congress Press Release – updated:...